FORMULATION R HEMORRHOIDAL OINTMENT 0.25 % — DIN 02246389
PHENYLEPHRINE HYDROCHLORIDE : 0.25 % PETROLATUM : 71.9 % MINERAL OIL : 14 % SHARK LIVER OIL : 3 % · G&W LABORATORIES INC. · OINTMENT · wholesale supply in Canada
Health Canada status: CANCELLED (UNRETURNED ANNUAL)
What is FORMULATION R HEMORRHOIDAL OINTMENT?
FORMULATION R HEMORRHOIDAL OINTMENT 0.25 % contains PHENYLEPHRINE HYDROCHLORIDE : 0.25 % PETROLATUM : 71.9 % MINERAL OIL : 14 % SHARK LIVER OIL : 3 %. It is listed in the Health Canada Drug Product Database under DIN 02246389, held by G&W LABORATORIES INC., supplied as OINTMENT for TOPICAL administration. Health Canada currently lists it as cancelled (unreturned annual), status dated 13-Sep-2017. This Drug Identification Number is no longer authorized for sale in Canada, so Nexara does not supply it. The record is kept here because buyers still meet the number on old formularies, purchase orders and tender documents; Nexara can help identify an authorized alternative.
Is there a generic Other Preparations, Combinations in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
10 holders have a Canadian DIN containing Other Preparations, Combinations, across 14 DINs, of which 2 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| PERRIGO INTERNATIONAL | 3 | 1 | HEMORRHOIDAL OINTMENT, HEMORRHOIDAL RELIEF OINTMENT | Sourceable in Canada |
| HALEON CANADA ULC | 1 | 1 | PREPARATION H-PE GEL | Sourceable in Canada |
| G&W LABORATORIES INC. | 3 | 0 | FORMULATION R HEMORRHOIDAL OINTMENT, FORMULATION R HEMORRHOIDAL SUPPOSITORIES, HEMORRHOIDAL COOLING GEL | No marketed DIN |
| ALERA SKIN CARE PRODUCTS INC. | 1 | 0 | ZENSA ANORECTAL GEL | No marketed DIN |
| INNOVUS PHARMACEUTICALS INC | 1 | 0 | XYRALID HEMORRHOIDAL SUPPOSITORIES | No marketed DIN |
| LALANI RX CONSULTING INC. | 1 | 0 | NUMB SQUEEZE | No marketed DIN |
| NATURE'S WAY OF CANADA LTD. | 1 | 0 | HEM-RELIEF ONT | No marketed DIN |
| PHARMA PAC LLC | 1 | 0 | HEMORRHOIDAL SUPPOSITORIES | No marketed DIN |
| TRIAD PHARMACEUTICALS | 1 | 0 | HEMORRHOIDAL SUPPOSITORIES | No marketed DIN |
| WHITEHALL-ROBINS INC. | 1 | 0 | PREPARATION H CLEANSING PADS | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 0.25 % |
|---|---|
| Dosage form | OINTMENT |
| Route | TOPICAL |
Pack detail is kept as a regulatory record. This DIN is no longer authorized for sale in Canada, so Nexara does not quote this pack.
Substance and classification
| Active substance | Other Preparations, Combinations |
|---|---|
| ATC code | C05AX03 |
| AHFS class | 84:92.00 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02246389 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2246389 |
| Brand name | FORMULATION R HEMORRHOIDAL OINTMENT |
| Generic / active ingredient | PHENYLEPHRINE HYDROCHLORIDE : 0.25 % PETROLATUM : 71.9 % MINERAL OIL : 14 % SHARK LIVER OIL : 3 % |
| Market authorization holder | G&W LABORATORIES INC. |
| Health Canada schedule | NON-PRESCRIPTION DRUGS |
| ATC code | C05AX03 |
| ATC anatomical main group | C — Cardiovascular system |
| ATC therapeutic subgroup | C05AX |
| Current status | CANCELLED (UNRETURNED ANNUAL) |
| Status date | 13-Sep-2017 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
2 of 14 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| HEMORRHOIDAL OINTMENT | 0.25 % | OINTMENT | PERRIGO INTERNATIONAL | MARKETED | 02501252 |
| PREPARATION H-PE GEL | 50 % | GEL | HALEON CANADA ULC | MARKETED | 02209594 |
| FORMULATION R HEMORRHOIDAL SUPPOSITORIES | 5.5 MG | SUPPOSITORY | G&W LABORATORIES INC. | CANCELLED (UNRETURNED ANNUAL) | 02248286 |
| HEM-RELIEF ONT | 85 % | OINTMENT | NATURE'S WAY OF CANADA LTD. | CANCELLED POST MARKET | 00656259 |
| HEMORRHOIDAL COOLING GEL | 0.25 % | GEL | G&W LABORATORIES INC. | CANCELLED (UNRETURNED ANNUAL) | 02327287 |
| HEMORRHOIDAL OINTMENT | 71.9 % | OINTMENT | PERRIGO INTERNATIONAL | CANCELLED POST MARKET | 02215845 |
| HEMORRHOIDAL RELIEF OINTMENT | 0.25 % | OINTMENT | PERRIGO INTERNATIONAL | CANCELLED POST MARKET | 02230466 |
| HEMORRHOIDAL SUPPOSITORIES | 3.0 % | SUPPOSITORY | TRIAD PHARMACEUTICALS | CANCELLED POST MARKET | 02290065 |
| HEMORRHOIDAL SUPPOSITORIES | 85.5 % | SUPPOSITORY | PHARMA PAC LLC | CANCELLED POST MARKET | 02382156 |
| NUMB SQUEEZE | 0.25 % | GEL | LALANI RX CONSULTING INC. | APPROVED | 02534010 |
2 · Same class — other molecules in ATC C05AX
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Other Preparations, Combinations | FORMULATION R HEMORRHOIDAL OINTMENT · FORMULATION R HEMORRHOIDAL SUPPOSITORIES · HEM-RELIEF ONT · HEMORRHOIDAL COOLING GEL · +8 more | 14 | 2 | Yes |
| Other Agents For Treatment Of Hemorrhoids And Anal Fissures For Topical Use | ANTI HEMORRHOIDAL H SUPPOSITORY · APZ HEMORRHOIDAL SUPPOSITORIES · HEMORRHOIDAL SUPPOSITORIES | 4 | 0 | Not in Canada |
| Zinc Preparations | ANU-AIDE - ONT TOP 0.5% · HEMO-PIC | 2 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC C05A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| C05AA | Hydrocortisone · Hydrocortisone, Combinations | 37 | 10 |
| C05AD | Anesthetics, Combinations · Benzocaine · Cinchocaine · Lidocaine · Pramocaine · +1 more | 23 | 3 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled (unreturned annual) in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.